Skip to search formSkip to main contentSkip to account menu

Enoxaparin

Known as: Enoxaparin [Chemical/Ingredient], Enoxaparine 
A low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin… 
National Institutes of Health

Related topics

Related topics

30 relations
0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe0.6 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe [Lovenox]0.8 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe [Lovenox]Angina, Unstable

Broader (2)

AnticoagulantsFibrinolytic Agents

Narrower (5)

ClexaneEMT-966Enoxaparin sodiumLovenox

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The safety and efficacy of full‐ versus reduced‐dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended‐Duration Betrixaban (APEX) trial
Highly Cited
2010
Highly Cited
2010
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
2006
2006
Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS.
Highly Cited
2005
Highly Cited
2005
A Retroperitoneal Bleed Induced by Enoxaparin Therapy
Retroperitoneal bleeding is one of the most serious, potentially lethal complications of antico-agulation therapy. Although well… 
Highly Cited
2004
Highly Cited
2004
Effect of Renal Function on the Pharmacokinetics of Enoxaparin and Consequences on Dose Adjustment
The use of weight-adjusted enoxaparin dosage in patients with renal failure results in increased bleeding complications. The… 
Highly Cited
2001
Highly Cited
2001
The effect of cold on the occurrence of bruising, haematoma and pain at the injection site in subcutaneous low molecular weight heparin.
Highly Cited
2001
Highly Cited
2001
Excessive anticoagulation in patients with mild renal insufficiency receiving long‐term therapeutic enoxaparin
Low‐molecular‐weight heparins, such as enoxaparin, are increasingly being used for treatment of venous thromboembolism. We… 
Highly Cited
2000
Highly Cited
2000
Patient-Centered Research: Predictors of Rehospitalization for Symptomatic Venous Thromboembolism After Total Hip Arthroplasty: A Case-Contol Study.
PURPOSE Recent studies have shown that symptomatic venous thromboembolism (VTE) frequently develops after hospital discharge… 
1998
1998
Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference…
1991
1991
Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)